PharmaTher Launches M3DICINES(TM) National Network Program to Provide 3D-Printed Medicines for Rare Diseases, Discontinued Medicines, Drug Shortages and National Emergencies Oct 7, 2026 08:00AM
PharmaTher Outlines Corporate Strategy and Upcoming Milestones; Launches New Corporate Website and Rebrands PERSONALIZ3D as M3DICINES Oct 5, 2026 08:00AM
PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform Oct 1, 2026 08:00AM
Medicus Pharma completes $2.97 million acquisition of Antev Limited Sep 2, 2025 07:32AM
Medicus Pharma Ltd. Completes Acquisition of Antev Limited Sep 2, 2025 07:30AM